Skip to content

Tangram Therapeutics vs PROTEINA

Tangram Therapeutics logo

Tangram Therapeutics

Relentless medicine discovery

32 employees · est. 2003 · London, United Kingdom

VS
PROTEINA logo

PROTEINA

Our Protein-protein interaction (PPI) analysis platform enables quantitative measurements at the single-molecule level

32 employees · est. 2015 · Seoul, Korea South

Tangram Therapeutics is the older company (2003 vs 2015).

Side-by-Side Comparison

Tangram Therapeutics PROTEINA
Founded
2003 older 2015
Headquarters
London, United Kingdom Seoul, Korea South
Employees
32 32
Industry
Biotechnology, Health Care Biotechnology, Health Care, Life Sciences
Funding Stage
Venture round Series C
Total Funding
$130.90M $19.00B
Funding Rounds
5 2
Services
Development of RNAi medicines, Computational drug discovery, Clinical trials for new therapeutics, Exploration of novel biological targets Not tracked yet
Target Customers
Healthcare providers, Patients with unmet medical needs, Pharmaceutical companies, Biotechnology investors Not tracked yet
Taxonomy
BiotechDrug DiscoveryRNA InterferenceComputational BiologyMedicine DevelopmentProprietary Computational Systems +8 Protein-protein InteractionPPI AnalysisSingle-molecule Co-immunoprecipitationQuantitative MeasurementsDrug Efficacy ModelingProtein Analysis +7
Website
etherapeutics.co.uk proteina.co.kr
Tangram Therapeutics logo

About Tangram Therapeutics

Tangram Therapeutics, formerly known as e-therapeutics, is a dynamic biotechnology startup founded in 2003 and headquartered in the United Kingdom. Touting the slogan, "Relentless medicine discovery," the company is dedicated to revolutionizing the field of healthcare by integrating computation, RNA...

PROTEINA logo

About PROTEINA

PROTEINA is a biotechnology startup based in South Korea, founded in 2015. The company has revolutionized protein analysis with its first-in-class protein-protein interaction (PPI) analysis platform, utilizing proprietary 'single-molecule co-immunoprecipitation' technology for quantitative measureme...

Also comparing in this category

Comparing more than these two?

Get Tangram Therapeutics, PROTEINA and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does Tangram Therapeutics compare?

A PDF of Tangram Therapeutics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Rival Readout

Comparing competitors? We do this properly.

10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.

Frequently Asked Questions

Tangram Therapeutics was founded in 2003, based in London, United Kingdom, with 32 employees. Tangram Therapeutics, formerly known as e-therapeutics, is a dynamic biotechnology startup founded in 2003 and headquartered in the United Kingdom. Touting the slogan, "Relentless medicine discovery,". PROTEINA was founded in 2015, based in Seoul, Korea South, with 32 employees. PROTEINA is a biotechnology startup based in South Korea, founded in 2015. The company has revolutionized protein analysis with its first-in-class protein-protein interaction (PPI) analysis platform,.
Tangram Therapeutics has raised $130.90M and PROTEINA $19.00B. Latest stage: Tangram Therapeutics Venture round, PROTEINA Series C.
Both work in Biotechnology and Health Care and list drug discovery among their focus areas.

Compare Tangram Therapeutics with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Tangram Therapeutics on 21 Sep 2026, and PROTEINA on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout